Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

0 Mėgstami
0Krepšelis

Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases

-22% su kodu: BOOKS
198,18 
Įprasta kaina: 254,08 
-22% su kodu: BOOKS
Kupono kodas: BOOKS
Akcija baigiasi: 2025-03-09
-22% su kodu: BOOKS
198,18 
Įprasta kaina: 254,08 
-22% su kodu: BOOKS
Kupono kodas: BOOKS
Akcija baigiasi: 2025-03-09
-22% su kodu: BOOKS
2025-02-28 198.18 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

This book contains a compendium of induced pluripotent stem cells (iPSCs) articles and reviews concerning state of the art technologies and how they are being applied to human neurodevelopmental disorders. With the establishment of effective technologies to produce iPSCs and their derivatives, like neural precursors, neurons, and glia, researchers have new platforms to study neurodevelopmental disorders. iPSC technology enables researchers to study how human neurons develop in individuals with neurodevelopmental disorders, providing an unparalleled opportunity to investigate their etiology. In turn, researchers have now begun to understand the underlying molecular and cellular pathways that contribute to human diseases. iPSCs technologies also provide an emerging tool for future translational studies and disease classification. The chapters will emphasize how among the diverse idiopathic and genetic disorders, there are common clinical as well as cellular andmolecular phenotypes.

Informacija

Serija: Advances in Neurobiology
Leidėjas: Springer Nature Switzerland
Išleidimo metai: 2020
Knygos puslapių skaičius: 316
ISBN-10: 3030454924
ISBN-13: 9783030454920
Formatas: 241 x 160 x 23 mm. Knyga kietu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases“

Būtina įvertinti prekę

Goodreads reviews for „Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases“